Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination

NCT01866566 is registered in ClinicalTrials.gov with Beijing Center for Disease Control and Prevention as lead sponsor.

NCT NCT01866566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01866566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Lead sponsor
Beijing Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2013
Completion date
January 31, 2016
Enrollment
1,800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

varicella